×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Shree Ganesh Remedies Limited | NA | NA | NA | NA | 754.0 | 34.5 |
| Prevest Denpro Limited | NA | NA | NA | NA | 668 | 35.3 |
| KILITCH DRUGS (INDIA) LTD. | 376.17 | 47.94 | 341.22 | 2.98 | 634 | 22.6 |
Shree Ganesh Remedies Limited, with Security Code 540737, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22.0 | 29.3 | 26.7 | 33.4 | 28.0 | 37.3 | 24.8 | 32.3 | 27.1 | 24.4 |
| Expenses | 16.6 | 21.1 | 20.0 | 24.2 | 19.8 | 20.4 | 16.7 | 21.0 | 17.2 | 14.5 |
| Operating Profit | 5.4 | 8.3 | 6.8 | 9.2 | 8.2 | 16.9 | 8.1 | 11.3 | 9.9 | 9.9 |
| OPM % | 24.42% | 28.18% | 25.34% | 27.6% | 29.35% | 45.35% | 32.78% | 34.98% | 36.59% | 40.59% |
| Other Income | 1.4 | 0.4 | 0.7 | 0.8 | 1.1 | 1.3 | 0.5 | 0.2 | 0.7 | 2.3 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.4 | 0.4 | 1.0 |
| Depreciation | 1.0 | 1.0 | 1.0 | 1.4 | 1.9 | 1.9 | 2.0 | 2.4 | 2.7 | 2.4 |
| Profit before tax | 5.8 | 7.6 | 6.5 | 8.6 | 7.4 | 16.3 | 6.3 | 8.6 | 7.5 | 8.8 |
| Tax % | -24.6% | -23.1% | -26.6% | -23.9% | -35.3% | -22.5% | -26.6% | -25.8% | -27.9% | -23.9% |
| Net Profit | 4.4 | 5.9 | 4.8 | 6.6 | 4.8 | 12.6 | 4.7 | 6.4 | 5.4 | 6.6 |
| EPS in Rs | 3.62 | 4.78 | 3.86 | 5.32 | 3.84 | 10.01 | 3.62 | 4.98 | 4.23 | 0 |
| Metrics | Mar 2020 | Sep 2021 | Dec 2021 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 31.6 | 17.0 | 21.1 | 37.3 | 24.8 | 32.3 | 27.1 | 24.4 |
| Expenses | 25.4 | 12.5 | 15.4 | 20.4 | 16.7 | 21.0 | 17.2 | 14.5 |
| Operating Profit | 6.3 | 4.4 | 5.8 | 16.9 | 8.1 | 11.3 | 9.9 | 9.9 |
| OPM % | 19.75% | 26.19% | 27.35% | 45.36% | 32.78% | 34.98% | 36.59% | 40.61% |
| Other Income | 2.2 | 0.4 | 0.9 | 1.3 | 0.5 | 0.2 | 0.7 | 2.3 |
| Interest | 0.5 | 0.0 | 0.0 | 0.2 | 0.3 | 0.4 | 0.4 | 1.0 |
| Depreciation | 1.2 | 1.0 | 1.0 | 1.9 | 2.0 | 2.4 | 2.7 | 2.4 |
| Profit before tax | 6.8 | 3.9 | 5.6 | 16.2 | 6.3 | 8.6 | 7.5 | 8.8 |
| Tax % | -21.7% | -22.6% | -25.4% | -22.5% | -26.6% | -25.8% | -27.9% | -23.9% |
| Net Profit | 5.3 | 3.0 | 4.2 | 12.6 | 4.6 | 6.4 | 5.4 | 6.6 |
| EPS in Rs | 5.9 | 3.02 | 3.5 | 10 | 3.62 | 4.97 | 4.22 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 13% |
| 3 Years: | 15% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 19% |
| 3 Years: | 20% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 62% |
| 3 Years: | 32% |
| 1 Year: | 2% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 11% |
| 3 Years: | 0% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | 0% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 62% |
| 3 Years: | 32% |
| 1 Year: | 2% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|